Furfenorex
From Wikipedia, the free encyclopedia
Furfenorex
|
|
Systematic (IUPAC) name | |
N-(furan-2-ylmethyl)-N-methyl-1-phenylpropan-2-amine | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C15H19NO |
Mol. mass | 229.317 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Furfenorex (Frugalan) is a stimulant drug derived from amphetamine, which was developed in the 1960s and used as an appetite suppressant for the treatment of obesity.[1] It produces methamphetamine as a metabolite,[2] and is no longer used, probably due to problems with abuse.
[edit] References
- ^ Boissier JR, Dumont C, Ratouis R, Moisy D. Pharmacologic study of an anorexigenic agent: furfenorex. (French). Archives Internationales de Pharmacodynamie et de Therapie. 1967 May;167(1):150-62.
- ^ Marsel J, Doring G, Remberg G, Spiteller G. Methamphetamine - a metabolite of the anorectics Benzphetamine and Furfenorex. (German). Zeitschrift fur Rechtsmedizin. 1972;70(4):245-50.